NCT04885543已完成不适用
Observational Study of the Clinico-biological Evolution and the Standard of Care Offered to Symptomatic Covid-19 Patients in Sub-Saharan Africa
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,495
- 试验地点
- 3
- 主要终点
- Mortality
研究概览
简要总结
This study was conducted in three African countries on four COVID-19 care centers (CCCs). The CCCs were set up in collaboration with a medical NGO with long experience in recording and monitoring data for cohorts and clinical trials in emergency contexts. The data were recorded using the WHO COVID-19 rapid core case report form.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •SARS-CoV-2 positive at RT-PCR
排除标准
- •Asymptomatic patients
结局指标
主要结局
Mortality
时间窗: During hospitalization, with an average of 11 days
In hospital mortality
次要结局
- Clinical worsening(Hospitalization, with an average of 11 days)
研究者
研究点 (3)
Loading locations...
相似试验
Unknown
不适用
COVID-19 - Cytokine StormCOVID-19NCT04474067Hadassah Medical Organization300
已完成
不适用
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120COVID-19NCT04814914Kaleido Biosciences333
已完成
不适用
Characteristics and Outcome of Patients With COVID-19 in ICUs in South TyrolCOVID-19COVID-19 Acute Respiratory Distress SyndromeNCT05077319Institute of Mountain Emergency Medicine550
招募中
不适用
Clinical and Biological Predictors of COVID-19 Disease in Older PatientsCOVID-19NCT04348396Istituto Nazionale di Ricovero e Cura per Anziani300
招募中
不适用
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.Indolent B-Cell Non-Hodgkin LymphomaCOVID-19Chronic Lymphocytic LeukemiaNCT05803395Gruppo Italiano Malattie EMatologiche dell'Adulto954